CN100490880C - Chinese medicinal composition for treating rheumatic and rheumatoid arthritis - Google Patents
Chinese medicinal composition for treating rheumatic and rheumatoid arthritis Download PDFInfo
- Publication number
- CN100490880C CN100490880C CNB2004100047555A CN200410004755A CN100490880C CN 100490880 C CN100490880 C CN 100490880C CN B2004100047555 A CNB2004100047555 A CN B2004100047555A CN 200410004755 A CN200410004755 A CN 200410004755A CN 100490880 C CN100490880 C CN 100490880C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- processed
- root
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating rheumatosis, rheumatic fever, chronic infectious arthritis, stiffness spondylitis, wherein the traditional Chinese medicinal composition comprises vomiting nut, cassia twig, wood louse, Chinese flowering quince, Chinese ephedra, eucommia bark, Cibotium barometz, ledebouriella root, frankincense, spatholobus stem, notopterygium root, homalomena rhizoma, Kusnezoff monkshood root, achyranthes and cyathula root, licorice root, Sichuan aconite root, safflower, gastrodia tuber, myrrh, dragon's blood resin, native copper and puncturevine. The medicament features in high curative rate and stronger pain relieving action.
Description
Technical field
The present invention relates to a kind of treatment rheumatism, rheumatoid Chinese medicine composition.Chinese medicine composition of the present invention also can be used for treating ankylosing spondylitis, aseptic necrosis of femoral head, amyotrophy, spinal neuratrophia, postpartum rheumatic arthromyodynia, synovitis, lupus erythematosus, sciatic neuropathy, numb limbs and tense tendons etc.
Background technology
Rheumatism, rheumatoid disease " stupid ", " difficulty ", " being tired of ", obstinate, outbreak is suffered hardships the patient repeatedly, makes the doctor have a headache.According to world Center for Disease Control (CDC): rheumatism, rheumatoid disease are the difficult miscellaneous diseases of another serious threat human health after cancer, and at present in the U.S., Europe and Japanese, rheumatism, rheumatoid disease patient crowd are up to nearly 300,000,000 people.An investigation in China some areas shows, more than 45 years old in the age group, have 85% people in various degree suffer from this disease, Zhi Fu medical expense is up to several hundred million units thus, and also has the trend that further increases.If delay treatment can directly threaten heart, part patient the joint can occur and disable and viscera function depletion.Estimate that according to the relevant expert 50% rheumatism, rheumatoid patient appearance paralysis are arranged the whole year.The western medicine instant effect, but cure the symptoms, not the disease, drug withdrawal is promptly recurred, and side effect is very big, easily causes lifelong disease and complication, as the injured nerve system, internal organs such as Liver and kidney cause the endocrine disturbance, diseases such as gastrorrhagia, drawbacks such as existing Chinese medicine curative effect is single, and produce effects is slow, and cure rate is low, and the course of treatment is long.Therefore, press for the medicine of effective treatment rheumatism, rheumatoid disease.
Summary of the invention
Therefore, the purpose of this invention is to provide a kind of effective treatment rheumatism, rheumatic fever, rheumatoid arthritis, ankylosing spondylitis, aseptic necrosis of femoral head, amyotrophy, spinal neuratrophia, postpartum rheumatic arthromyodynia, synovitis, lupus erythematosus, sciatic neuropathy, numb limbs and tense tendons etc., especially the Chinese medicine composition of rheumatism, rheumatoid arthritis, it has characteristics such as cure rate height, treatment time are short, and analgesic effect is strong and rapid.
This Chinese medicine composition comprises following raw material by weight:
Semen Strychni 10-40 Ramulus Cinnamomi 3-20 Eupolyphaga Seu Steleophagas 8-35
Fructus Chaenomelis 3-25 Herba Ephedraes 10-120 Cortexs Eucommiae 3-25
Rhizoma Cibotii 10-100 Radix Saposhnikoviaes 3-25 Olibanums 3-25
Caulis Spatholobi 3-30 Rhizoma Et Radix Notopterygiis 3-25 Rhizoma Homalomenaes 3-25
Radix Aconiti Kusnezoffii 3-25 Radix Achyranthis Bidentataes 3-25 Radix Glycyrrhizaes 3-25
Radix Aconiti 3-25 Flos Carthamis 3-25 Rhizoma Gastrodiaes 5-40
Myrrha 3-25 Sanguis Draxonis 5-25 Pyritums 3-25
Fructus Atriplicis Sibiricae 3-25.
Chinese medicine composition of the present invention preferably includes following raw material by weight:
Semen Strychni 20-35 Ramulus Cinnamomi 7-10 Eupolyphaga Seu Steleophagas 20-30
Fructus Chaenomelis 7-10 Herba Ephedraes 80-100 Cortexs Eucommiae 7-10
Rhizoma Cibotii 45-55 Radix Saposhnikoviaes 3-25 Olibanums 3-25
Caulis Spatholobi 7-10 Rhizoma Et Radix Notopterygiis 7-10 Rhizoma Homalomenaes 7-10
Radix Aconiti Kusnezoffii 7-10 Radix Achyranthis Bidentataes 7-10 Radix Glycyrrhizaes 7-10
Radix Aconiti 7-10 Flos Carthamis 7-10 Rhizoma Gastrodiaes 8-15
Myrrha 3-25 Sanguis Draxonis 8-15 Pyritums 7-10
Fructus Atriplicis Sibiricae 7-10.
Chinese medicine composition of the present invention more preferably comprises following raw material by weight:
Semen Strychni (processed) 30 Ramulus Cinnamomi 8 Eupolyphaga Seu Steleophagas 25
The Fructus Chaenomelis 8 system Herba Ephedraes 100 system Cortexs Eucommiae 8
System Rhizoma Cibotii 50 Radix Saposhnikoviaes 8 Olibanum (processed)s 8
Caulis Spatholobi 8 Rhizoma Et Radix Notopterygiis 8 Rhizoma Homalomenaes 8
Radix Aconiti Kusnezoffii Preparata 8 Radix Achyranthis Bidentataes 8 Radix Glycyrrhizae Preparatas 8
Radix Aconiti Preparata 8 Flos Carthamis 8 Rhizoma Gastrodiaes 10
Myrrha (processed) 8 Sanguis Draxonis 10 Pyritum (processed) 8
Fructus Atriplicis Sibiricae 8.
Said components can be used as medicine by crude drug, or is used as medicine with their any extract.Can Chinese medicine composition of the present invention be made suitable dosage form according to conventional method, as pill, capsule, granule, oral liquid, concentrated pill etc., even external preparation.For example, each raw material of the present invention can be ground into powder, mix, incapsulate, make capsule; Maybe each raw material of the present invention can be ground into powder, sieve, make the honeyed pill or the watered pill; Maybe each raw material water of the present invention can be decocted 1-4 times, preferred 2-3 times, filter and remove residue is made oral liquid; Perhaps each raw material water of the present invention or ethanol can be extracted 2-3 times under heating, filter the rear filtrate precipitate with ethanol, concentrating under reduced pressure is dried again, makes concentrated pill after the pulverizing.
Above-mentioned prescription has the relaxing muscles and tendons to promote blood circulation blood stasis dispelling, expelling wind and cold, and dredge the meridian passage, the strong bone of strong muscle, hard masses softening and resolving, invigorating the liver and kidney, anti-inflammatory analgetic suppresses hyperosteogeny, recovers the effect of human body function.Can be used for treating rheumatism, rheumatic fever, rheumatoid arthritis, ankylosing spondylitis, aseptic necrosis of femoral head, amyotrophy, spinal neuratrophia, postpartum rheumatic arthromyodynia, synovitis, lupus erythematosus, sciatic neuropathy, numb limbs and tense tendons etc.
Find after deliberation, effective ingredient of the present invention can be blocked each link of rheumatism atrophic arthritis morbidity rapidly, suppress the formation of immune complex, by improving local blood circulation, reduce capillary permeability again, alleviate and diminish inflammation and ooze out, strengthening the tendons and bones, liver and kidney tonifying improves joint deformity, diminish inflammation and dysfunction, thereby reach the purpose of radical cure.Can make rheumatic and rheumatoid patient's erythrocyte sedimentation rate reach 200mm/ hour, anti-chain " O " returns to below 250 units, and rheumatoid factor is turned out cloudy by sun.
Because indivedual excessive uses of raw material have certain toxicity in the prescription of the present invention, so pharmaceutical composition of the present invention is generally with 3-50g, the amount of living crude drug gross weight/day of preferred 10-30g is used, can divide 1-4 application, and, strengthen consumption gradually preferably to begin in a small amount.
The specific embodiment
Below illustrate with embodiment.
Embodiment 1
Semen Strychni (processed) 10g Ramulus Cinnamomi 8g Eupolyphaga Seu Steleophaga 30g
Fructus Chaenomelis 8g system Herba Ephedrae 80g system Cortex Eucommiae 15g
System Rhizoma Cibotii 70g Radix Saposhnikoviae 6g Olibanum (processed) 12g
Caulis Spatholobi 20g Rhizoma Et Radix Notopterygii 8g Rhizoma Homalomenae 8g
Radix Aconiti Kusnezoffii Preparata 6g Radix Achyranthis Bidentatae 8g Radix Glycyrrhizae Preparata 20g
Radix Aconiti Preparata 6g Flos Carthami 8g Rhizoma Gastrodiae 15g
Myrrha (processed) 12g Sanguis Draxonis 10g Pyritum (processed) 8g
Fructus Atriplicis Sibiricae 8g
Said medicine is shredded roughly, decocted 1 hour down at 100 ℃, filter with 8 times of water gagings, filtering residue decocted 1 hour with 8 times of water gagings again, filter, merge 2 times filtrate, filtrate is used precipitate with ethanol, concentrating under reduced pressure again, oven dry is pulverized, and adds an amount of excipient (as starch) and magnesium stearate and granulates, reinstall capsule, every capsules 0.5g.
Embodiment 2
Semen Strychni (processed) 30g Ramulus Cinnamomi 8g Eupolyphaga Seu Steleophaga 25g
Fructus Chaenomelis 8g system Herba Ephedrae 100g system Cortex Eucommiae 8g
System Rhizoma Cibotii 50g Radix Saposhnikoviae 8g Olibanum (processed) 8g
Caulis Spatholobi 8g Rhizoma Et Radix Notopterygii 8g Rhizoma Homalomenae 8g
Radix Aconiti Kusnezoffii Preparata 8g Radix Achyranthis Bidentatae 8g Radix Glycyrrhizae Preparata 8g
Radix Aconiti Preparata 8g Flos Carthami 8g Rhizoma Gastrodiae 10g
Myrrha (processed) 8g Sanguis Draxonis 10g Pyritum (processed) 8g
Fructus Atriplicis Sibiricae 8g
Above-mentioned raw materials is pulverized,,, made the watered pill with controlling the water circulation ball machine then after 100 mesh sieves with each raw material mix homogeneously.
Embodiment 3
Semen Strychni (processed) 23g Ramulus Cinnamomi 8g Eupolyphaga Seu Steleophaga 25g
Fructus Chaenomelis 8g system Herba Ephedrae 100g system Cortex Eucommiae 8g
System Rhizoma Cibotii 60g Radix Saposhnikoviae 8g Olibanum (processed) 8g
Caulis Spatholobi 20g Rhizoma Et Radix Notopterygii 8g Rhizoma Homalomenae 8g
Radix Aconiti Kusnezoffii Preparata 8g Radix Achyranthis Bidentatae 8g Radix Glycyrrhizae Preparata 15g
Radix Aconiti Preparata 8g Flos Carthami 8g Rhizoma Gastrodiae 15g
Myrrha (processed) 8g Sanguis Draxonis 10g Pyritum (processed) 8g
Fructus Atriplicis Sibiricae 8g
Above-mentioned raw materials is pulverized, and with each raw material mix homogeneously, after 100 mesh sieves, in incapsulating then, every capsules contains medicated powder 0.5g.
The medicine of above embodiment was taken 2 months per course of treatment, and every day 1-2 times, preferred day clothes are once slept and taken in preceding 10 minutes, each 0.5-6g, preferred 1-3g.Behind the transference cure, take 1-2 courses of treatment again.
Medicine of the present invention is through hundreds of routine patient treatments, and the result shows that effective percentage is 100%, and most of patient obtains curing, purpose that can reach clinical cure the course of treatment of patients with mild, and severe patient is clinical to be shown:
A course of treatment: inflammation is eliminated, arthralgia, and muscle swelling is heavy, aching and tired discomfort, stiff symptom such as ineffective is eased.
Two courses of treatment: breakage tissue, cell obtain repairing, and each diseased region is swollen, bloated, numb, sour phenomenon begins to disappear, and limb activity freely.
Three courses of treatment: the diseased region blood circulation is vigorous, and immunity improves, and arthritis, scapulohumeral periarthritis, cervical spondylosis, waist and leg ache, hyperosteogeny reach clinical cure.
And, medicine of the present invention has the advantage of quickly alleviating pain, and pain added reconstructed image after medication can appear in indivedual rheumatoid patient, this be because, under drug effect, make impaired diseased region occluding vascular mediation, restoration of blood flow causes hydrarthrosis to increase, the articular cavity internal pressure increases, because impaired articular cavity pathological changes is heavier, can not resembles timely penetrating hydrops the natural joint, thereby the phenomenon that pain increases the weight of occurs in a period of time.Can alleviate after continuing to take, and rehabilitation gradually.
Claims (5)
1, a kind of treatment rheumatism, rheumatic fever, the Chinese medicine composition of rheumatoid arthritis or postpartum rheumatic arthromyodynia, make the raw materials of effective components medicine and consist of by weight:
Semen Strychni (processed) 10-40 Ramulus Cinnamomi 3-20 Eupolyphaga Seu Steleophagas 8-35
Fructus Chaenomelis 3-25 Herba Ephedraes 10-120 Cortexs Eucommiae 3-25
Rhizoma Cibotii 10-100 Radix Saposhnikoviaes 3-25 Olibanums 3-25
Caulis Spatholobi 3-30 Rhizoma Et Radix Notopterygiis 3-25 Rhizoma Homalomenaes 3-25
Radix Aconiti Kusnezoffii 3-25 Radix Achyranthis Bidentataes 3-25 Radix Glycyrrhizaes 3-25
Radix Aconiti 3-25 Flos Carthamis 3-25 Rhizoma Gastrodiaes 5-40
Myrrha 3-25 Sanguis Draxonis 5-25 Pyritums 3-25
Fructus Atriplicis Sibiricae 3-25.
2, according to the Chinese medicine composition of claim 1, the weight portion of each raw material is:
Semen Strychni (processed) 20-35 Ramulus Cinnamomi 7-10 Eupolyphaga Seu Steleophagas 20-30
Fructus Chaenomelis 7-10 Herba Ephedraes 80-100 Cortexs Eucommiae 7-10
Rhizoma Cibotii 45-55 Radix Saposhnikoviaes 3-25 Olibanums 3-25
Caulis Spatholobi 7-10 Rhizoma Et Radix Notopterygiis 7-10 Rhizoma Homalomenaes 7-10
Radix Aconiti Kusnezoffii 7-10 Radix Achyranthis Bidentataes 7-10 Radix Glycyrrhizaes 7-10
Radix Aconiti 7-10 Flos Carthamis 7-10 Rhizoma Gastrodiaes 8-15
Myrrha 3-25 Sanguis Draxonis 8-15 Pyritums 7-10
Fructus Atriplicis Sibiricae 7-10.
3, according to the Chinese medicine composition of claim 1, the weight portion of each raw material is:
Semen Strychni (processed) 30 Ramulus Cinnamomi 8 Eupolyphaga Seu Steleophagas 25
The Fructus Chaenomelis 8 system Herba Ephedraes 100 system Cortexs Eucommiae 8
System Rhizoma Cibotii 50 Radix Saposhnikoviaes 8 Olibanum (processed)s 8
Caulis Spatholobi 8 Rhizoma Et Radix Notopterygiis 8 Rhizoma Homalomenaes 8
Radix Aconiti Kusnezoffii Preparata 8 Radix Achyranthis Bidentataes 8 Radix Glycyrrhizae Preparatas 8
Radix Aconiti Preparata 8 Flos Carthamis 8 Rhizoma Gastrodiaes 10
Myrrha (processed) 8 Sanguis Draxonis 10 Pyritum (processed) 8
Fructus Atriplicis Sibiricae 8.
4, the method for each pharmaceutical composition in the preparation claim 1-3 comprises described each raw material water or ethanol is extracted 2-3 times under heating, extracts after-filtration at every turn, merging filtrate, and filtrate is used precipitate with ethanol, and concentrating under reduced pressure is dried again, incapsulates after the pulverizing.
5, the method for each pharmaceutical composition in the preparation claim 1-3 comprises described each raw material is ground into powder, sieves, and makes the honeyed pill or the watered pill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100047555A CN100490880C (en) | 2004-03-03 | 2004-03-03 | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100047555A CN100490880C (en) | 2004-03-03 | 2004-03-03 | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1663577A CN1663577A (en) | 2005-09-07 |
CN100490880C true CN100490880C (en) | 2009-05-27 |
Family
ID=35035005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100047555A Expired - Fee Related CN100490880C (en) | 2004-03-03 | 2004-03-03 | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100490880C (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732588B (en) * | 2010-01-18 | 2012-12-05 | 李英明 | Formula of Chinese medicament for treating bodily pain syndrome |
CN102335304B (en) * | 2010-07-20 | 2013-06-05 | 天津中新药业集团股份有限公司达仁堂制药厂 | Chinese medicine composition for dispelling wind, removing dampness, invigorating blood circulation, and relieving pain and preparation method thereof |
CN103169876B (en) * | 2013-02-26 | 2015-02-04 | 孙胜波 | Chinese medicament composition for treating arthralgia |
CN103638248B (en) * | 2013-12-12 | 2015-07-01 | 徐士杰 | Medicine for treating gonarthromeningitis and preparation method of medicine |
CN106309954A (en) * | 2016-11-07 | 2017-01-11 | 穆林涛 | Plaster for treating osteopathy |
CN107970422A (en) * | 2018-01-29 | 2018-05-01 | 寿县永安中医专科医院 | A kind of rheumatism ball and its production technology |
CN110876792A (en) * | 2018-08-23 | 2020-03-13 | 湖南安华银发科技有限公司 | Borneol plaster for relaxing muscles and tendons and activating collaterals |
-
2004
- 2004-03-03 CN CNB2004100047555A patent/CN100490880C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1663577A (en) | 2005-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
CN101428096B (en) | Chinese medicinal composition for treating femoral head necrosis and preparation method thereof | |
CN101099839A (en) | External-applied traditional Chinese medicine bag and using method thereof | |
CN103006951A (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
CN100534513C (en) | Chinese medicinal ointment for treating bones and tendons injury pain | |
CN100998656A (en) | Medicated wine for tonifying bone and removing obstruction in channels | |
CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
CN100490880C (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
CN101690768A (en) | Vein and artery relieving pills for impediment of sinew | |
CN103446360B (en) | Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation | |
CN103006879A (en) | Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof | |
CN102274457A (en) | Physiotherapy enhanced spray for scraping and massaging | |
CN101496838A (en) | Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof | |
CN104306880A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
CN114452347A (en) | A composition for treating pain in neck, shoulder, waist and leg, and prolapse of lumbar intervertebral disc, and its preparation method | |
CN103784824A (en) | Chinese herbal preparation for treating lumbar disc herniation and rheumatoid | |
CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
CN105311210A (en) | Pharmaceutical composition for treating rheumatoid bone diseases | |
CN104013734A (en) | Traditional Chinese medicine oral liquid for treating osteoarthritis | |
CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
CN101041021A (en) | Chinese medicines composition took orally for treating vrain apoplexy | |
CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
CN102988762A (en) | Plaster for treating traumatic fracture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090527 Termination date: 20180303 |
|
CF01 | Termination of patent right due to non-payment of annual fee |